Hypoxia and HIF pathway in cancer and the placenta |
| |
| Affiliation: | 1. Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Health Sciences, University of Nottingham, LE12 5RD, UK;2. School of Medicine and Sciences, University of Nottingham, Nottingham City Hospital, NG5 1PB, UK;3. Department of Urology, Nottingham University Hospitals NHS Trust, NG5 1PB, UK;4. School of Pharmacy, University of Nottingham, NG7 2TQ, UK;5. Department of Pathology, Weill Cornell Medicine, New York 10065, USA;6. School of Biosciences, University of Nottingham, LE12 5RD, UK;7. Department of Translational Medicine, Lund University, Malmö, Sweden;8. Department of Molecular Biology, Umeå University, Sweden;9. Department of Immunology and Microbiology, University of Copenhagen, Denmark;10. Kazan Federal University, Kazan, Republic of Tatarstan 420008, Russian Federation;11. Department of Paediatrics, University of Cambridge, Hills Rd, Cambridge CB2 0QQ, UK;12. Department of Pharmacology, Weill Cornell Medicine, New York 10065, USA;1. Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom;2. Department of Emergency Medicine, University of Mississippi Medical Centre, Jackson, MS, USA;1. Department of Gynecology Obstetrics, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva 1211, Switzerland;2. Department of Internal Medicine Specialities, HUG, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland |
| |
| Abstract: | |
| |
| Keywords: | Oxygen Hypoxia-inducible factor Placenta Trophoblast Cancer CCRCC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0040" }," $$" :[{" #name" :" text" ," _" :" clear cell renal cell carcinoma FasL" },{" #name" :" keyword" ," $" :{" id" :" kwrd0050" }," $$" :[{" #name" :" text" ," _" :" Fas ligand FIH" },{" #name" :" keyword" ," $" :{" id" :" kwrd0060" }," $$" :[{" #name" :" text" ," _" :" factor inhibiting HIF FLT1" },{" #name" :" keyword" ," $" :{" id" :" kwrd0070" }," $$" :[{" #name" :" text" ," _" :" fms-related tyrosine kinase 1 HIF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0080" }," $$" :[{" #name" :" text" ," _" :" hypoxia-inducible factor HLA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0090" }," $$" :[{" #name" :" text" ," _" :" human leukocyte antigen MHC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0100" }," $$" :[{" #name" :" text" ," _" :" major histocompatibility complex mTOR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0110" }," $$" :[{" #name" :" text" ," _" :" mechanistic target of rapamycin NK cell" },{" #name" :" keyword" ," $" :{" id" :" kwrd0120" }," $$" :[{" #name" :" text" ," _" :" natural killer cell PD-1" },{" #name" :" keyword" ," $" :{" id" :" kwrd0130" }," $$" :[{" #name" :" text" ," _" :" programmed cell death 1 PD-L1" },{" #name" :" keyword" ," $" :{" id" :" kwrd0140" }," $$" :[{" #name" :" text" ," _" :" programmed cell death ligand 1 PHD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0150" }," $$" :[{" #name" :" text" ," _" :" prolyl hydroxylase domain-containing protein PlGF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0160" }," $$" :[{" #name" :" text" ," _" :" placental growth factor VEGF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0170" }," $$" :[{" #name" :" text" ," _" :" vascular endothelial growth factor VEGFR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0180" }," $$" :[{" #name" :" text" ," _" :" vascular endothelial growth factor receptor VHL" },{" #name" :" keyword" ," $" :{" id" :" kwrd0190" }," $$" :[{" #name" :" text" ," _" :" von Hippel-Lindau |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
